Prognostic factors for ovarian metastases in colorectal cancer patients

被引:3
作者
Chen, Chao [1 ]
Wang, Da [1 ]
Ge, Xiaoxu [1 ,2 ]
Wang, Jian [1 ]
Huang, Yuhuai [1 ]
Ling, Tianyi [1 ]
Jin, Tian [1 ]
Yang, Jinhua [3 ]
Wang, Fengping [3 ]
Wu, Weihong [3 ]
Sun, Lifeng [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Key Lab Canc Prevent & Intervent, Dept Colorectal Surg & Oncol,Minist Educ,Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Canc Inst, Hangzhou, Zhejiang, Peoples R China
[3] Changxing Cty Peoples Hosp, Dept Gastrointestinal Surg, Huzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Colorectal cancer; Ovarian metastases; Prognosis factors; Cytoreductive surgery; Scoring system; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; PERITONEAL CARCINOMATOSIS; APPENDICEAL; SURVIVAL; OOPHORECTOMY; IMPACT; TUMOR; NOMOGRAM; HIPEC;
D O I
10.1186/s12957-021-02305-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The aim of this study was to analyze prognostic factors for ovarian metastases (OM) in colorectal cancer (CRC) using data from a Chinese center. In addition, the study aimed at developing a new clinical scoring system for prognosis of OM of CRC patients after surgery. Patients and methods Data of CRC patients with OM were collected from a single Chinese institution (n = 67). Kaplan-Meier analysis was used to evaluate cumulative survival of patients. Factors associated with prognosis of overall survival (OS) were explored using Cox's proportional hazard regression models. A scoring system to determine effectiveness of prognosis was developed. Results Median OS values for patients with or without surgery were 22 and 7 months, respectively. Size of OM, number of OM, peritoneal metastasis (PM), Peritoneal cancer index (PCI), and completeness of cytoreduction (CC) were associated with OS of patients through univariate analysis. Multivariate analysis using a Cox regression model showed that only CC was an independent predictor for OS. Three variables (the size of OM >15cm, PCI >= 10, and carcinoembryonic antigen (CEA) >30 ng/mL) assigned one point each were used to develop a risk score. The resulting score was used for prognosis of OS. Conclusion Surgical treatment of metastatic sites is effective and safe for CRC patients with OM. CC-0 is recommended for improved prognosis. The scoring system developed in this study is effective for prediction of OS of patients after surgery.
引用
收藏
页数:11
相关论文
共 37 条
[1]   Complete resection of colorectal cancer with ovarian metastases combined with chemotherapy is associated with improved survival [J].
Al-Busaidi, Ibrahim S. ;
Bailey, Teresa ;
Dobbs, Bruce ;
Eglinton, Tim W. ;
Wakeman, Christopher J. ;
Frizelle, Frank A. .
ANZ JOURNAL OF SURGERY, 2019, 89 (09) :1091-1096
[2]   Peritoneal spillage is not an issue in patients undergoing minimally invasive surgery for colorectal cancer [J].
Ambe, Peter C. ;
Kankam, Joseph ;
Zarras, Konstantinos .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
[3]   Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer [J].
Bignell, M. B. ;
Mehta, A. M. ;
Alves, S. ;
Chandrakumaran, K. ;
Dayal, S. P. ;
Mohamed, F. ;
Cecil, T. D. ;
Moran, B. J. .
COLORECTAL DISEASE, 2018, 20 (08) :704-710
[4]  
Bray F., 2018, CA Cancer J ClinAnticancer Res, DOI DOI 10.3322/CAAC.21492
[5]   The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-O4 study [J].
Byun, Jae Ho ;
Ahn, Joong Bae ;
Kim, Sun Young ;
Kang, Jung Hun ;
Zang, Dae Young ;
Kang, Seok Yun ;
Kang, Myoung Joo ;
Shim, Byoung Yong ;
Baek, Sun Kyung ;
Kim, Bong-Seog ;
Lee, Kyung Hee ;
Lee, Soon Il ;
Cho, Sang-Hee ;
Sohn, Byeong Seok ;
Kim, Samyong ;
Hwang, In Gyu ;
Nam, Eun Mi ;
Seo, Bong-Gun ;
Oh, Sang Cheul ;
Lee, Myung-Ah ;
Lee, Sang-Cheol ;
Hong, Ji Hyung ;
Park, Young Suk .
KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (01) :165-177
[6]   Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy [J].
Canda, Aras Emre ;
Arslan, Cigdem ;
Terzi, Cem ;
Sokmen, Selman ;
Yavuzsen, Tugba ;
Ozkardesler, Sevda ;
Unlu, Mehtat ;
Obuz, Funda ;
Fuzun, Mehmet .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
[7]   Patient Selection for Cytoreductive Surgery in Colorectal Peritoneal Carcinomatosis Using Serum Tumor Markers An Observational Cohort Study [J].
Cashin, Peter H. ;
Graf, Wilhelm ;
Nygren, Peter ;
Mahteme, Haile .
ANNALS OF SURGERY, 2012, 256 (06) :1078-1083
[8]   Impact of the Peritoneal Surface Disease Severity Score on Survival in Patients with Colorectal Cancer Peritoneal Carcinomatosis Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy [J].
Chua, Terence C. ;
Morris, David L. ;
Esquivel, Jesus .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (05) :1330-1336
[9]   External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal Cancer [J].
Demey, Karel ;
Wolthuis, Albert ;
van Overstraeten, Anthony de Buck ;
Fieuws, Steffen ;
Vandecaveye, Vincent ;
Van Cutsem, Eric ;
D'Hoore, Andre .
ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (12) :3604-3608
[10]   Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases [J].
Di Giorgio, Angelo ;
De Iaco, Pierandrea ;
De Simone, Michele ;
Garofalo, Alfredo ;
Scambia, Giovanni ;
Pinna, Antonio Daniele ;
Verdecchia, Giorgio Maria ;
Ansaloni, Luca ;
Macri, Antonio ;
Cappellini, Paolo ;
Ceriani, Valerio ;
Giorda, Giorgio ;
Biacchi, Daniele ;
Vaira, Marco ;
Valle, Mario ;
Sammartino, Paolo .
ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (04) :914-922